Insights

  • Date

  • Content Type

  • Reset

Blog

Fit-for-purpose immunogenicity assays: What to consider during assay development and validation?

23.02.21

by Nermina Vejzagic

Unwanted immune responses in the form of anti-drug antibodies (including neutralizing antibodies) can be induced...

Blog

Recent progress in xenotransplantation – a new way to fight donor organ shortage

02.02.21

by Masin Abo-Rady and Jörg Schneider

The growing worldwide shortage of donor organs is the biggest challenge for...

Blog

The regulatory environment for the development of mRNA vaccines during COVID-19

07.12.20

by Ciaran Greene

A growing interest in mRNA-based technologies over the last decades has allowed the rapid development...

Blog

Covid and consultancy – combating a global health crisis with unprecedented scientific and regulatory solutions

01.12.20

by Michael Pfleiderer

2020 certainly exceeded everybody’s expectations in any major area of everyday life and work. Read...

Blog

Biomarkers in drug development: a double-edged sword?

30.11.20

by Mariya Gromova and Aleksandra Nevmerzhitskaya

In the 21st century the term biomarkers is no longer strictly associated...

Blog

Vaccine Development in Paediatric Populations – How to Proceed for SARS-CoV-2 Vaccines?

05.11.20

by Jerry Fuady

While adult clinical trials of SARS-CoV-2 vaccines have rapidly moved into Phase 3, no clinical...